Friday, 11 May 2018

CMS approves national reimbursement coverage for CardiAMP Chronic Myocardial Ischemia Trial

BioCardia®, Inc., a leader in the development of comprehensive solutions for #Cardiovascular regenerative therapies, today announced that the Centers for Medicare and Medicaid Services (CMS) has approved national reimbursement coverage for the CardiAMP Chronic Myocardial Ischemia Trial.

For more details, PS: http://bit.ly/2KwdiAZ

No comments:

Post a Comment